Scientist reviewing microscope imaging data on monitor

Advancing Next-Generation Sequencing with Scientific Insight and Integrated Expertise

Q: Can you support both tissue and liquid biopsy samples?

Yes. We support a broad range of sample types, including FFPE tissue, plasma, blood, and other biological matrices. Our workflows are designed to handle different sample inputs while maintaining consistency in processing and data generation across studies.

Q: How do you ensure data quality and consistency?

We use standardized workflows, automated extraction platforms, and validated bioinformatics pipelines across our global laboratory network. This harmonized approach helps ensure that genomic data is reproducible, comparable across sites, and suitable for downstream analysis and regulatory use.

From biomarker discovery to clinical development, generate meaningful insights through end-to-end next-generation sequencing (NGS) capabilities, expert scientific guidance, and globally harmonized delivery.

Turning complex genomic data into meaningful biological insight

NGS studies require careful decisions long before sequencing begins. Selecting the right strategy, sample type, and analytical approach is critical to generating data that aligns with your scientific objectives and delivers meaningful biological insight.

By translating this complex information into actionable insights, these decisions can help advance the development of more targeted therapies and ultimately improve outcomes for patients.

With decades of genomics expertise, we deliver end-to-end NGS solutions tailored to your study needs, from sample preparation and sequencing through to bioinformatics, interpretation, and reporting. Our globally harmonized workflows and advanced sequencing capabilities enable reliable, scalable delivery across complex clinical research programs, transforming genomic data into meaningful insights that support the development of targeted therapies.

Delivering the expertise your program demands

Comprehensive genomics platforms

Close up of multichannel pipette tips above a transparent well plate

Broad range of NGS technologies and sequencing platforms
Support for DNA, RNA, and ctDNA analysis
High-throughput, automated workflows

Expertise across multiple applications

Close up of automated laboratory liquid handling system with well plates

Solid and liquid tumor profiling
Hereditary and rare disease genomics
Infectious disease and microbiome sequencing
Cell and gene therapy support

Flexible and tailored assay solutions

Medium shot of female scientist working at a bright biosafety cabinet

Off-the-shelf and custom panel development
OncoSign and broad-panel genomic assays
Fit-for-purpose validation aligned to study endpoints

Global, harmonized delivery model

Medium close up of male scientist using electronic pipette C

Integrated project management and scientific teams
Standardized workflows across global labs
Scalable execution for multi-site clinical trials
Fast and efficient turnaround time

End-to-end NGS capabilities

From sample collection to reporting, our end-to-end genomics workflow connects sample collection, sequencing, and data analysis, ensuring consistency from upstream processing to reporting.

End-to-end genomics workflow, from sample collection and DNA/RNA extraction through library preparation, sequencing, and downstream bioinformatics analysis and reporting.

Integrated genomics capabilities

Close-up of gloved hands operating a multichannel pipette above sample tubes A

Tissue and liquid biopsy

Generate genomic insights from diverse sample types, including FFPE tissue, plasma, PBMCs, blood, and body fluids, enabling flexible NGS study designs across therapeutic areas.

Close up of multichannel pipette positioned above a transparent laboratory well plate C

Library preparation

Ensure reliable sequencing data through automated library preparation workflows and leading NGS technologies, including Illumina, PacBio®, Ion Torrent™, and Oxford Nanopore platforms.

Abstract microscope imaging view of biological sample

Data analysis and clinical-grade reporting

Translate complex sequencing data into meaningful biological insight through validated bioinformatics pipelines that identify and characterize genomic alterations relevant to your research objectives.

Close up of automated pipetting system dispensing samples into a laboratory well plate B

Multi-omic integration

Combine NGS data with complementary technologies, including qPCR, digital droplet PCR (ddPCR), NanoString® gene expression platforms, cytogenetics, and immune repertoire sequencing to build a more complete understanding of disease biology.

Our NGS technologies and sequencing platforms

Supported by FDA-regulated and CE-IVD-marked systems, our technology platform ensures consistent, high-quality data generation across all sequencing workflows.

NGS platforms (Illumina MiSeqDx™, NextSeq™ 500, NextSeq™ 2000, NextSeq™ 550Dx)
Quantitative PCR (qPCR) systems (Roche cobas® 4800)
Digital droplet PCR (ddPCR) platforms (Bio-Rad QX200™ Droplet Digital™ PCR System with AutoDG™)
Sanger sequencing and fragment analysis systems (Applied Biosystems™ 3500 Genetic Analyzer)

View all technologies and platforms

Scientist operating automated genomics analyser from workstation

NGS FAQ

What types of sequencing services do you offer?

We provide a comprehensive range of genomics services, including targeted next-generation sequencing panels, whole exome sequencing, RNA sequencing, and liquid biopsy analysis. These approaches can be tailored to your study objectives, enabling you to select the most appropriate strategy based on the depth of analysis and type of biological insight required.

Can you support both tissue and liquid biopsy samples?

What genomic alterations can you analyze through NGS?

Our validated bioinformatics pipelines support the analysis of a broad range of genomic alterations, including:

Single nucleotide variants (SNVs)
Insertions and deletions (indels)
Copy number variants (CNVs)
Gene fusions and rearrangements
Tumor mutational burden (TMB)
Microsatellite instability (MSI)
Minimal residual disease (MRD)
Homologous recombination deficiency (HRD)

How do you ensure data quality and consistency?

Enquiries

"*" indicates required fields

X/Twitter

This field is for validation purposes and should be left unchanged.

First name*

Last name*

Email*

Phone*

Job function*

Company*

Country*

Therapeutic area*

Stay in the loop with our latest updates

Opt IN to receive updates from Cerba Research

What are your needs?

Please give some additional information about your request if you want
By submitting information on this form, you are agreeing to the terms of our Privacy Policy. You have the right to unsubscribe from email communication at any time.

Advancing Next-Generation Sequencing with Scientific Insight and Integrated Expertise

Turning complex genomic data into meaningful biological insight